L

LEXX

Lexaria Bioscience Corp

0.81

-0.02-2.35%
Closed19:13 07/15 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Cash from Operating Activities

-4.96M

-5.88M

-4.88M

-3.99M

-2.62M

Net Income

-5.81M

-6.71M

-7.38M

-4.19M

-4.08M

Depreciation/Depletion & Amortization

76.15K

145.40K

102.72K

111.72K

112.75K

Deferred Taxes

--

--

--

--

--

Non-Cash Items

666.94K

542.63K

2.75M

21.23K

1.55M

Changes in Working Capital

106.56K

143.26K

-351.48K

63.53K

-194.36K

Cash from Investing Activities

-188.61K

-169.61K

-180.64K

193.88K

-26.84K

Capital Expenditures

-188.61K

-169.61K

-180.64K

-79.49K

-33.65K

Other Investing Cash Flow Items, Total

--

--

--

273.37K

6.80K

Cash from Financing Activities

10.32M

1.59M

-44.60K

13.42M

2.65M

Financing Cash Flow Items

--

--

--

--

--

Total Cash Dividends Paid

--

--

--

--

--

Issuance (Retirement) of Stock, Net

10.32M

1.59M

0

13.49M

2.67M

Issuance (Retirement) of Debt, Net

--

0

-44.60K

-66.69K

-13.83K

Foreign Exchange Effects

-19.82K

--

--

--

--

Net Change in Cash

5.15M

-4.46M

-5.10M

9.62M

8.60K

Cash Interest Paid

--

--

--

--

--

Cash Taxes Paid

10.04K

-8.21K

4.78K

16.30K

12.98K